Objective Rituximab is a monoclonal antibody directed against the CD20 marker of B cells.
Because of its ability to deplete B lymphocytes, it has been suggested that the drug could be …

Objective: To evaluate efficacy, serological responses, and predictors of response in
patients with severe and refractory systemic lupus erythematosus (SLE) treated with …

Background Clinical practice is essential for health care students. The supervisor's role and
how supervision should be organized are challenging issues for educators and clinicians …

Background It is well known that patients' involvement in health care students' learning is
essential and gives students opportunities to experience clinical reasoning and practice …

Background Students express difficulty transforming their knowledge in nursing science and
theories into action in clinical practice (Andersson and Edberg, 2010). Studies also show …

Objectives. The aims of this study were to investigate hand function in PM and DM patients
and compare this with reference values in healthy individuals and also to investigate if hand …

Background: The monoclonal anti-B cell antibody rituximab (Rituxin, Mabthera) may be of
benefit in antibody-driven diseases, including systemic lupus erythematosus (SLE) nephritis …

Objective. The aim of this study was to describe women's experience of SLE-related fatigue,
how they express the feeling of fatigue, impact on life and strategies developed to manage …

Objective Accumulating evidence supports an impaired health‐related quality of life (HRQ
oL) in patients with systemic lupus erythematosus (SLE). We investigated the effects of 2 …

Canine systemic lupus erythematosus (SLE) has a similar disease expression as human
SLE, but the serological characterisation of the canine disease is as yet incomplete. In the …